---
figid: PMC3491838__emmm0004-1087-f2
figlink: /pmc/articles/PMC3491838/figure/fig02/
number: Figure 2
caption: 'Metabolites are shown in plain text and enzymes in blue boxes. Abbreviations
  for enzymes are as follows: PARP, poly(ADP-ribose) polymerase; NAMPT, nicotinamide
  phosphoribosyl transferase; NMNAT, nicotinamide mononucleotide adenylyl transferase;
  NAPRT, nicotinic acid phosphoribosyl transferase; NADS, NAD synthase. PARP reactions
  require β-NAD+ as a substrate and generate nicotinamide as a by-product of the PARSylation
  of proteins. In cells where PARPs are highly active, β-NAD+ is largely provided
  by a salvage pathway that utilizes nicotinamide. Nicotinamide is processed back
  to β-NAD+ by two enzymes, NAMPT and NMNAT, with NAMPT catalysis representing the
  rate limiting step in this process. Alternatively, β-NAD+ can be synthesized de
  novo from either nutritional tryptophan (via the kynurenine pathway) or via NA,
  which is processed by NAPRT, NMNAT and NADS.'
pmcid: PMC3491838
papertitle: Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast
  cancer cells.
reftext: Ilirjana Bajrami, et al. EMBO Mol Med. 2012 Oct;4(10):1087-1096.
pmc_ranked_result_index: '147864'
pathway_score: 0.7686203
filename: emmm0004-1087-f2.jpg
figtitle: Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast
  cancer cells
year: '2012'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3491838__emmm0004-1087-f2.html
  '@type': Dataset
  description: 'Metabolites are shown in plain text and enzymes in blue boxes. Abbreviations
    for enzymes are as follows: PARP, poly(ADP-ribose) polymerase; NAMPT, nicotinamide
    phosphoribosyl transferase; NMNAT, nicotinamide mononucleotide adenylyl transferase;
    NAPRT, nicotinic acid phosphoribosyl transferase; NADS, NAD synthase. PARP reactions
    require β-NAD+ as a substrate and generate nicotinamide as a by-product of the
    PARSylation of proteins. In cells where PARPs are highly active, β-NAD+ is largely
    provided by a salvage pathway that utilizes nicotinamide. Nicotinamide is processed
    back to β-NAD+ by two enzymes, NAMPT and NMNAT, with NAMPT catalysis representing
    the rate limiting step in this process. Alternatively, β-NAD+ can be synthesized
    de novo from either nutritional tryptophan (via the kynurenine pathway) or via
    NA, which is processed by NAPRT, NMNAT and NADS.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PARP10
  - PARP3
  - PARP12
  - NAMPT
  - PARP9
  - PARP11
  - NMNAT1
  - WDTC1
  - PARP2
  - PARP6
  - PARP16
  - NAPRT
  - TNKS2
  - PARP8
  - PARP14
  - PARP1
  - TNKS
  - TIPARP
  - PARP4
  - PARP15
  - nicotinic acid mononucleotide
  - nicotinic acid adenine dinucleotide
  - NADS
  - nicotinamide
  - nicotinamide mononucleotide
  - nicotinic acid
  - poly ADP ribose
  - Tryptophan
genes:
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: NMNAT
  symbol: NMNAT
  source: hgnc_alias_symbol
  hgnc_symbol: NMNAT1
  entrez: '64802'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: NAPRT
  symbol: NAPRT
  source: hgnc_symbol
  hgnc_symbol: NAPRT
  entrez: '93100'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
chemicals:
- word: nicotinic acid mononucleotide
  source: MESH
  identifier: C002953
- word: nicotinic acid adenine dinucleotide
  source: MESH
  identifier: C018348
- word: NADS
  source: MESH
  identifier: C055737
- word: nicotinamide
  source: MESH
  identifier: D009536
- word: nicotinamide mononucleotide
  source: MESH
  identifier: D009537
- word: nicotinic acid
  source: MESH
  identifier: D009539
- word: poly ADP ribose
  source: MESH
  identifier: D011064
- word: Tryptophan
  source: MESH
  identifier: D014364
diseases: []
---
